Cargando…

Enhanced Anti-tumor Reactivity of Cytotoxic T Lymphocytes Expressing PD-1 Decoy

Programmed death-1 (PD-1) is a strong negative regulator of T lymphocytes in tumor-microenvironment. By engaging PD-1 ligand (PD-L1) on tumor cells, PD-1 on T cell surface inhibits anti-tumor reactivity of tumor-infiltrating T cells. Systemic blockade of PD-1 function using blocking antibodies has s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Jae Hun, Park, Hyung Bae, Choi, Kyungho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2016
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853499/ https://www.ncbi.nlm.nih.gov/pubmed/27162530 http://dx.doi.org/10.4110/in.2016.16.2.134

Ejemplares similares

Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
por: Chen, Jiming, et al.
Publicado: (2022)

Interleukin‐12 Augments the Generation of Autologous Tumor‐reactive CD8(+) Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes
por: Kuge, Soichi, et al.
Publicado: (1995)

Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH
por: Stsiapanava, Alena, et al.
Publicado: (2022)

Longitudinal Intravital Imaging of Tumor-Infiltrating Lymphocyte Motility in Breast Cancer Models
por: Park, Inwon, et al.
Publicado: (2021)

Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells
por: Abdul Rahman, Siti Fairus, et al.
Publicado: (2022)

ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8(+) cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy
por: Li, Chunyang, et al.
Publicado: (2015)

Evidence that Amphotericin B Mediates Reactivation of Latent Epstein-Barr Virus in Hodgkin's Lymphoma Allowing Cytotoxicity by Acyclovir
por: Kast, Richard E.
Publicado: (2006)

Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes
por: Marotte, L, et al.
Publicado: (2021)

Evaluation of the Extraction Method for the Cytotoxicity Testing of Latex Gloves
por: Baek, Hyun Sook, et al.
Publicado: (2005)

Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors
por: Kang, Da Hyun, et al.
Publicado: (2020)

Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor
por: Zhao, Jingjing, et al.
Publicado: (2023)

Ras inhibition by FTS attenuates brain tumor growth in mice directly and by enhancing reactivity of cytotoxic lymphocytes
por: Aizman, Elizabeta, et al.
Publicado: (2012)

STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer
por: Pantelidou, Constantia, et al.
Publicado: (2022)

Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
por: Mysinger, Michael M., et al.
Publicado: (2012)

Two-Round Mixed Lymphocyte Reaction for Evaluation of the Functional Activities of Anti-PD-1 and Immunomodulators
por: Kwon, Minsuk, et al.
Publicado: (2018)

Anti-inflammatory properties of butyrate-producing atypical Escherichia coli in a murine colitis model
por: Kim, Ji Hyung, et al.
Publicado: (2023)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
por: Loi, Sherene, et al.
Publicado: (2022)

DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
por: Gilfillan, Susan, et al.
Publicado: (2008)

CYTOTOXIC THYMUS-DERIVED LYMPHOCYTES IN CEREBROSPINAL FLUID OF MICE WITH LYMPHOCYTIC CHORIOMENINGITIS
por: Zinkernagel, R. M., et al.
Publicado: (1973)

Predictive Value of Decoy Receptor 3 in Postoperative Nosocomial Bacterial Meningitis
por: Liu, Yong-Juan, et al.
Publicado: (2014)

Evaluation of a novel virtual screening strategy using receptor decoy binding sites
por: Patel, Hershna, et al.
Publicado: (2016)

Vitamin C Is an Essential Factor on the Anti-viral Immune Responses through the Production of Interferon-α/β at the Initial Stage of Influenza A Virus (H3N2) Infection
por: Kim, Yejin, et al.
Publicado: (2013)

Assay Sensitivity Difference Can Induce Anti-Hepatitis A Virus IgM Non-Reactive But Total (IgM and IgG) Reactive Results in Early Acute Hepatitis A
por: Kim, Soo-Kyung, et al.
Publicado: (2022)

Preparation of Internal Quality Control Material for Lymphocyte Subset Analysis
por: Roh, Eun Youn, et al.
Publicado: (2016)

Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
por: Scognamiglio, Giosue, et al.
Publicado: (2019)

CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy
por: Park, Hyung Bae, et al.
Publicado: (2017)

Sucrose enhanced reactive oxygen species generation promotes cotton fibre initiation and secondary cell wall deposition
por: Ding, Xiaoyan, et al.
Publicado: (2021)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

DecoyFinder, a tool for finding decoy molecules
por: Adrià, Cereto Massagué, et al.
Publicado: (2012)

ROLE OF H-2 LYMPHOCYTE-DEFINED AND SEROLOGICALLY-DEFINED COMPONENTS IN THE GENERATION OF CYTOTOXIC LYMPHOCYTES
por: Alter, Barbara J., et al.
Publicado: (1974)

Decoy fitness peaks, tumor suppression, and aging
por: Higa, Kelly C., et al.
Publicado: (2019)

Tumor‐associated macrophages regulate the function of cytotoxic T lymphocyte through PD‐1/PD‐L1 pathway in multiple myeloma
por: Zhang, Jiangbo, et al.
Publicado: (2022)

Lymphocytic hypophysitis masquerading as pituitary adenoma
por: Mittal, Rajneesh, et al.
Publicado: (2012)

Role of CD8 in Aberrant Function of Cytotoxic T Lymphocytes
por: Kessler, Benedikt, et al.
Publicado: (1997)

MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma
por: Castillo, Lesley, et al.
Publicado: (2019)

Decoy Receptor Interactions as Novel Drug Targets against EKC-Causing Human Adenovirus
por: Chandra, Naresh, et al.
Publicado: (2019)

Hypersensitivity Cross-Reactivity for Ultrasound-Enhancing Agents and COVID-19 Vaccines
por: Desai, Anish K., et al.
Publicado: (2022)

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
por: Bevins, Nicholas J., et al.
Publicado: (2022)

High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response
Publicado: (1993)

High Toxoplasma gondii Seropositivity among Brain Tumor Patients in Korea
por: Jung, Bong-Kwang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_20e2b0uc9rjhmdclkjrfbrn0fo